Hyderabad

Jodas India is manufacturing and sourcing arm of Moscow (Russia) based Jodas Expoim. Till date, most of the Jodas’s products are manufactured in India.

Post: Deputy Manager - Production (1)

Bryogen Pharmaceuticals Pvt Ltd is a leading Pharmaceuticals company with Dermatology, Critical Care, Oncology division

Post: Regional Sales Manager

[adsense:336x280:8701650588]

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India. The Institute is conceived to provide leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa. NIPER is a member of Association of Indian Universities and Association of Commonwealth Universities.

Post: Junior Technical Assistant

A medical device MNC based in Hyderabad, R&D center based in hyderabad. Leading manufactureres of medical devices in the globe

Post: Software Project Manager

[adsense:336x280:8701650588]

Sree Vaageswari Educational society was established in 2003 and started Vaageswari College of Pharmacy with B.Pharmacy course in 2004 to honor SARASWATHI, the goddess of Education. We are working with a mission to provide the quality education in the field of Pharmacy profession and also to promote highest quality professional pharmacy education at all levels, to produce competent pharmacists, with entrepreneurship and innovative skills. We also wish to educate people regarding drugs, drug products, health and population control and also to create a model pharmacy in the institution to strengthen the relation between public and pharmacy.

Indian Institute of Chemical Technology (IICT), Hyderabad, a constituent of CSIR is a leading research Institute in the area of chemical sciences. The core strength of IICT lies in Organic Chemistry, and it continues to excel in this field for over six decades. The research efforts during these years have resulted in the development of several innovative processes for a variety of products necessary for human welfare such as drugs, agrochemicals, food, organic intermediates, adhesives etc.

Indian Pharmaceutical Association (IPA) is the premier professional association of pharmaceutical professionals in India. IPA is affiliated with international pharmaceutical associations, like Federation of Asian Pharmaceutical Associations (FAPA), Commonwealth Pharmaceutical Association (CPA), Asia Pacific Pharmaceutical Symposium (APPS), World Health Organization (WHO) & International Pharmaceutical Students’ Federation (IPSF) for carrying out various collaborative professional activities.

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.
We offer stimulating work environment & a career that spells growth. In tune with our plans, we require young, aggressive, dynamic, high performing and result oriented professional.

Post: Plant Head, DGM/GM, AGM, Senior Manager, Executive, Sr. Executive, Astt. Manager, Manager

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Suresh VV Babu¹, Talasila EGK Murthy²*, Chimakurthy Jithendra^3
1Dept. of Pharmaceutics, Natco Pharma Limited, Hyderabad, Telangana, India.
²Dept. of Pharmaceutics, Bapatla College of Pharmacy, Bapatla, Andhra Pradesh, India.
³Dept. of Pharmacology, Bapatla College of Pharmacy, Bapatla, Andhra Pradesh, India.
*drgkm@bcop.net

ABSTRACT
The present study was to assess the relative bioavailability and pharmacokinetic properties of extended release formulations of Ranolazine 1000 mg in healthy male volunteers usinga randomized, open-label, balanced, two-treatment, two-period, two sequence, single dose, crossover, bioequivalence study under fasting conditions. Bioavailability of the test product of Ranolazine extended release tablets 1000 mg was compared with that of the reference product of Ranexa® (Ranolazine extended release tablets 1000mg) of CV Therapeutics Inc., California. The plasma samples were collected at 0.50, 1.00, 1.50, 2.00, 2.50, 3.00, 3.50, 4.00, 4.50, 5.00, 5.50, 6.00, 6.50, 7.00, 8.00, 10.00, 12.00, 16.00, 24.00 and 48.00 hours post dose after single administration of Ranolazine 1000mg. The plasma Ranolazine concentrations were estimated by using a validated bioanalytical method by LC-MS/MS. A ten day washout period is followed between two treatments. The formulations were considered to be bioequivalent if the 90% CIs for the log-transformed values were within the predetermined equivalence range 80%–125% for AUC and C_max. For Ranolazine, at 90% confidence intervals C_max, AUC_0-tand AUC _0-∞ were 83.43-113.29, 82.10-102.87 and 80.94-101.85 for log-transformed data respectively.The present results show that the formulation of Ranolazine was bioequivalent to the reference in fasting, healthy, male volunteers.